Overview
Psoriasis is a long-lasting autoimmune-type condition in which the immune system mistakenly drives skin cells to grow far faster than normal, forming thick, red or discolored patches often topped with silvery scale. It commonly appears on the elbows, knees, scalp and lower back, but it can affect the nails, joints and skin folds as well, and it tends to flare and settle over time. It affects a meaningful share of adults worldwide and frequently runs in families, with both genetic and environmental triggers. Viewed through a full-body optimization lens, psoriasis matters because the immune signaling that shows up in the skin is associated in research with inflammation elsewhere in the body, including the joints, blood vessels and metabolism. Understanding these connections can help frame skin health as one visible window into a person's broader inflammatory and longevity picture.
The Underlying Biology
Psoriasis is driven by a self-reinforcing loop between the innate and adaptive immune systems and the skin's keratinocytes. A central pathway is the IL-23/Th17 axis: dendritic cells release interleukin-23 (IL-23), which sustains T-helper-17 (Th17) cells that secrete interleukin-17 (IL-17) and interleukin-22. These cytokines, alongside tumor necrosis factor-alpha (TNF-alpha) and interferon signaling, prompt keratinocytes to proliferate rapidly, so skin cells that normally mature over weeks turn over in days, producing the characteristic scaly plaques. The keratinocytes in turn release antimicrobial peptides and chemokines that recruit more immune cells, amplifying the cycle. Susceptibility is strongly genetic, with the HLA-C*06:02 allele and additional loci influencing risk, and flares are commonly linked to triggers such as infection, skin injury (the Koebner phenomenon), stress, smoking and certain medications. Importantly, this cytokine activity is not confined to the skin; research associates the same systemic inflammation with psoriatic arthritis, cardiovascular strain, insulin resistance and metabolic syndrome. Commonly discussed markers include C-reactive protein and inflammatory cytokines, reflecting the condition's whole-body inflammatory signature.
What the Research Explores
- Explores how the IL-23/IL-17 and TNF-alpha pathways drive the skin and systemic features of psoriasis
- Investigates whether reducing chronic inflammation is associated with skin, joint and cardiometabolic health
- Examines the research links between psoriasis, psoriatic arthritis and cardiovascular and metabolic markers
- Considers how modifiable factors such as stress, sleep, smoking and body composition relate to flare patterns
- Reviews how nutrition, omega-3 intake and gut-immune signaling are studied in relation to inflammatory skin conditions
- Frames skin-visible immune activity as one window into a person's broader inflammatory and longevity picture
Who May Find This Relevant
- People exploring psoriasis as part of a broader inflammatory and longevity picture
- Those with related concerns such as joint symptoms or cardiometabolic risk markers
- Individuals interested in how lifestyle, stress and nutrition relate to inflammatory skin conditions
- Anyone seeking a physician-guided, whole-body view of immune and skin health alongside their own care
Important Considerations
This information is educational only and is not intended to diagnose, treat, cure or prevent any disease. Psoriasis is a medical condition that should be diagnosed and managed with your own physician or dermatologist; any optimization support is decided one-on-one with Dr. Rob, based on your labs, personal history and goals. Individual situations vary, and nothing here replaces personalized medical care.
